Canada markets open in 9 hours 19 minutes

RetinalGenix Technologies Inc. (RTGN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.50000.0000 (0.00%)
At close: 01:47PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
606.165
809.255
747.808
431.557
Selling General and Administrative
1,004
1,067
1,429
1,646
Total Operating Expenses
1,004
1,876
2,177
1,646
Operating Income or Loss
-1,004
-1,876
-2,177
-1,646
Interest Expense
5.619
5.14
2.619
0
Total Other Income/Expenses Net
-2,639
-2,033
-680.293
-431.557
Income Before Tax
-3,649
-3,914
-2,179
-2,078
Income from Continuing Operations
-3,649
-3,914
-2,179
-2,078
Net Income
-3,649
-3,914
-2,179
-2,078
Net Income available to common shareholders
-3,649
-3,914
-2,179
-2,078
Basic EPS
-0.13
-0.25
-0.15
-0.15
Diluted EPS
-0.13
-0.25
-0.15
-0.15
Basic Average Shares
17,194
15,584
14,282
14,282
Diluted Average Shares
17,194
15,584
14,282
14,282